{"name":"Pyxis Oncology, Inc","slug":"pyxis-oncology-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxNcGZfOUp4Z2c0M09fWFpjQjg4VTRjdjVnb1hhclpSQXFnSDFRa0JsSjNPYkFkX0RGYVpMTkRBc3FBel9ueng2M1J3RlFNMzdBU3FQWG55Nm1PT1BneGR6VndoTkJlRE1sbWRuNWRkd0hkRlVPVm1HSDRydEZjdVY0Q2hhTWtJUXAxQkl6NVBqV0h0S2huTnZpc2NuTTAtcHNRS0tkMGtPUVhJNTE1ZGRkR19FNEFKYmpxTUpDWHZvaFA2OTZzX2k4QjE2Tk1KYUQ4Y3Ayb2N5U1BWSnpoZTYzTmdPLXBlY2U5V1FqTnlOaGE5T0pTT1dMbkg0SmNzTURCeXpSWnBOOHZvdw?oc=5","date":"2026-03-23","type":"pipeline","source":"minichart.com.sg","summary":"MicuRx Pharmaceuticals: Advancing Novel ADC Therapy MICVO for Difficult-to-Treat Head and Neck Cancer – Pipeline, Strategy, and Risks Overview - minichart.com.sg","headline":"MicuRx Pharmaceuticals: Advancing Novel ADC Therapy MICVO for Difficult-to-Treat Head and Neck Cancer – Pipeline, Strate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFBCVDV6VEJWbE1sMm5SaW44MWR6b2ZwRXVFSHgzck4xcUlxZkFQRUhoZXFnMkZ0Z0lKZEN6RFh3T2MxZklPQy14WjFDaE5ScjBXeFhRa0k3YU5hcFJyRXpSQWU3YjRPUk1GOGk3VldtNHF0a0tKbURtag?oc=5","date":"2026-02-03","type":"deal","source":"Intellectia AI","summary":"7 Best Stocks Under $5 That Experts Are Buying Now 2026 - Intellectia AI","headline":"7 Best Stocks Under $5 That Experts Are Buying Now 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5pWGdTaXRBT2tGUm9WR05yX2hzdmFHcUVxZ2RXbFBJVmQtdm91bmx0XzFIc3dwUzZmeHJIV0tWVFBGcWlWcy1FZ3BUTklRRGVyWUp3SlhFeGpndFBQ?oc=5","date":"2025-12-02","type":"pipeline","source":"Finimize","summary":"Pyxis’s Cancer Bet Has Paid Off So Far - Finimize","headline":"Pyxis’s Cancer Bet Has Paid Off So Far","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNOXdtUTFjMDdzc09wSXd0VVBWZWljRks0a0tpMGZWZi1EbV9rV3VERVdOR3RuZHFPY0E1WGpRbmRuNWc0ZlAwTERzLUExOGt6ZnI5MFN2YzdSbWdGUmxUdGlZTnoyTnlGcmFiVXhIalk1NHFQY09wZi05b0NoM2ZESFhwTmlJQ1RuajFMQjExYw?oc=5","date":"2025-10-15","type":"pipeline","source":"Yahoo Finance","summary":"Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics - Yahoo Finance","headline":"Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics an","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFAxbEJ0enhtWHNwei0yRkFrMHhwM0FkamhDcGVtRkNlbmpNcmRhbDFGSlY1SzVWbldlbHBfX0ZWS2s4Y0hRVTFFdTVzb0c3NWloUHhJeGJ2M3B5Z1B0VFFiMEdGQ3lTTjRqRmM2WUZSYTFKb1FOQm1UUA?oc=5","date":"2025-10-14","type":"deal","source":"Yahoo Finance","summary":"5 Small Drug Stocks to Buy as the Industry Shows Some Recovery - Yahoo Finance","headline":"5 Small Drug Stocks to Buy as the Industry Shows Some Recovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVGhudTlQdmVrczBXOEY2Z3pDTmNKSWhVNXZvM3Jka1Y3VkhKMFdZYzIyaE9fb240SklNeVhWWWppRFhERWNOZ0FSQ2d6eU9zc2JaWmdqMWdkc1Nub1pXOHk5dkpGNk1kcXJkbjJBVzZGS041dkg1ODJsYUxCOGE2bkMzMzF2RUgyTlFsZXQtOFU2VFdPenk4dzBYQ0FoVl9wWnhMT1RZSm8zZw?oc=5","date":"2025-06-10","type":"deal","source":"BioWorld News","summary":"Ligachem inks two mystery ADC deals with CSPC subsidiary Novarock - BioWorld News","headline":"Ligachem inks two mystery ADC deals with CSPC subsidiary Novarock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBScXRtQ0tnTHAtQ1RNeTQwUm9HcmNXWXVJUzg0NGo4b2dUVnVYSS01ekpBUlpXa1J0bDlpWlhham5ubzhYZXh4dW5yanlVR19ZSnc?oc=5","date":"2025-06-06","type":"trial","source":"Endpoints News","summary":"IPO Tracker (2021) - Endpoints News","headline":"IPO Tracker (2021)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBMUHF0V2lyNFJsTGxHeUZvYnZ4UWhJeU0taUhyMHFSSzBuWE13end1OFNrZThfU1hVVDdjM1dxNG5iUVUwMTF0QUxiVjVtX2ZlOUpZ?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"PYXS Stock Price, News & Analysis - Stock Titan","headline":"PYXS Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOWWZDWFR0RW1zRGJZMUpIZXZNcUx0QXFWVmgyS2JVSkctSG5reTNEREpmQjhid2JqanJtaF9EakwzcVFRTEp4cE1oSzQ2QmtoaTVPaTFOa0ZxSWM4aE4zVHU0VGRDdVcyaWQ4cDFCQlpuQno3b291WWVvbkJZT3JURw?oc=5","date":"2025-03-28","type":"regulatory","source":"Oncology News Central","summary":"Recent FDA Oncology Approvals: 5 Question Quiz - Oncology News Central","headline":"Recent FDA Oncology Approvals: 5 Question Quiz","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOOU9nOFNXYVB3M1JXMnhxUWkzMkY3TkpDOFJpQ2FwdjE5RjFPbDRyN2ZXRHVKQ0ZJOHc2endmQjNIY0FwNHBYWkx6WXlhN0ZDUG80M3FPbnc5NWItMEUwNUx0MjZzNnMwVndabFMwbHpHS01aWGhTNVYzOWJjZzAyYjNMSDV4cEpCZV9tOFo5dmhES29zRUVDZHRzUGk?oc=5","date":"2025-03-18","type":"pipeline","source":"Fierce Biotech","summary":"Pyxis lays off 20% of staff to swing behind single-candidate strategy - Fierce Biotech","headline":"Pyxis lays off 20% of staff to swing behind single-candidate strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9ZcDVZbFB4bjFzRVAyV3M4UXhBNE5TRHVuMnc2bVF6aTJ5R2NQeHZyWWJIWnVVT1NTZUo5Z1puZFNIc0Zybks3RlBpTkZ1VS1hdEVUUHJyTXJSYkpfejZJQlQ5SDc5OERTQXJFYg?oc=5","date":"2024-07-01","type":"pipeline","source":"The Pharma Letter","summary":"Pyxis Oncology - The Pharma Letter","headline":"Pyxis Oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQbTJXSmVOQXhxREVkdmhVc3A3a25WbS0zQk9POW1NSWQxTWQxdHBBMzA1Y2xJVUtnR3FPYVhaYkpiQkN6a2RyaXFvVHNqSnI0dXdnRGVpSXltRWUxcTBqZU9TcW9xQjdOYUc3RmgzMjlxenk5cWI2VDFHX0ZTSFczUUZ5aVVaOXlOd0NnRzlNUzRYMnlLQU5F?oc=5","date":"2023-05-24","type":"deal","source":"Contract Pharma","summary":"Pyxis Oncology to Acquire Apexigen in $16M Deal - Contract Pharma","headline":"Pyxis Oncology to Acquire Apexigen in $16M Deal","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}